Scott Reents
Director of Finance/CFO presso TOBIRA THERAPEUTICS INC
Patrimonio netto: 3 M $ in data 31/03/2024
Profilo
Scott T.
Reents is currently the President & Director at Allergan, Inc. and Oculeve, Inc. He is also the Chief Financial Officer & Executive Vice President at AbbVie, Inc. and the Chief Financial Officer at Tobira Therapeutics, Inc. Previously, he worked as the Vice President-Tax at Abbott Laboratories.
Mr. Reents completed his undergraduate degree at the University of Nebraska and holds graduate and MBA degrees from the University of Washington.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
ABBVIE, INC.
0.00% | 28/02/2024 | 15 431 ( 0.00% ) | 3 M $ | 31/03/2024 |
Posizioni attive di Scott Reents
| Società | Posizione | Inizio |
|---|---|---|
| TOBIRA THERAPEUTICS INC | Director of Finance/CFO | - |
| ABBVIE INC. | Director of Finance/CFO | 23/06/2022 |
| ALLERGAN, INC. | President | - |
Oculeve, Inc.
 Oculeve, Inc. Medical SpecialtiesHealth Technology Oculeve, Inc. develops devices for dry eye disease treatment. The company was founded by D. Michael Ackermann, Brandon M. Felkins, Garrett Cale Smith and Victor Wayne McCray in 2011 and is headquartered in Parsippany, NJ. | President | - |
Precedenti posizioni note di Scott Reents
| Società | Posizione | Fine |
|---|---|---|
| ABBOTT LABORATORIES | Comptroller/Controller/Auditor | - |
Formazione di Scott Reents
| University of Nebraska | Undergraduate Degree |
| University of Washington | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| ABBVIE INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
Oculeve, Inc.
Oculeve, Inc. Medical SpecialtiesHealth Technology Oculeve, Inc. develops devices for dry eye disease treatment. The company was founded by D. Michael Ackermann, Brandon M. Felkins, Garrett Cale Smith and Victor Wayne McCray in 2011 and is headquartered in Parsippany, NJ. | Health Technology |
Tobira Therapeutics, Inc.
 Tobira Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The company was founded on October 6, 2006 and is headquartered in Madison, NJ. | Health Technology |
- Borsa valori
- Insiders
- Scott Reents
